Associated Papers
Clinical Implementation of Pharmacogenomics and Drug-Drug Interaction Screening in a German Academic Teaching Hospital and Outpatient Follow-Up.
Tremmel R et al.
Clinical Pharmacology and Therapeutics, 2026
41074844 (PubMed )
Supplement: CPT-119-241-s005.pdf
Adult genomic medicine: lessons from a multisite study of 2700 patients.
Bakur K et al.
Genome Medicine, 2025
41024252 (PubMed )
Supplement: 13073_2025_1529_MOESM6_ESM.xlsx › Sheet1
Novel Pathogenic Variants in POLR3K Cause POLR3-Related Leukodystrophy.
Perrier S et al.
Human Mutation, 2024
The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.
Mhandire DZ et al.
Molecular Diagnosis & Therapy, 2022
UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays.
Gailite L et al.
Frontiers in Genetics, 2020
Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome.
Gailite L et al.
Bmc Pediatrics, 2018
Distribution of selected gene polymorphisms of UGT1A1 in a Saudi population.
Alkharfy KM et al.
Archives of Medical Science : Ams, 2013
Genetic variants and haplotypes of the UGT1A9, 1A7 and 1A1 genes in Chinese Han.
Zhang X et al.
Genetics and Molecular Biology, 2012
Select a paper to view details